Miyoshi T, Ogawa S, Kanamori T, Nobuhara M, Namba M
Cancer Lett. 1983 Jan;17(3):239-47. doi: 10.1016/0304-3835(83)90160-x.
A potentiation of the cytotoxic effects of 5-fluorouracil (5-FU) on human tumor cells by interferon was examined. The human neoplastic cell lines used were HeLa (uterine cervical cancer), MCF-7 (mammary cancer), WI-38 CT-1 (embryonic lung fibroblasts transformed in culture by Co-60 gamma-ray irradiation), KMM-1 (myeloma) and Raji (Burkitt's lymphoma). The normal human cell strain used was WI-38 (normal human lung fibroblasts). The cytotoxic effects were determined by colony formation for HeLa, MCF-7, WI-38 CT-1 and WI-38 cells, and by cell growth for KMM-1 and Raji cells. Each cell line was different in sensitivity to interferon or 5-FU. Interferon potentiated synergistically the cytotoxic effects of 5-FU on HeLa, WI-38 CT-1 and KMM-1 cells. In the case of Raji cells, the cytotoxic effects of the combination of interferon and 5-FU were additive. Neither synergistic nor additive lethal effects of the combination of the 2 agents were observed in MCF-7 and WI-38 cells. The present results indicate a possibility that interferon and 5-FU can mutally reduce the amount of the other needed to treat cancer patients.
研究了干扰素对5-氟尿嘧啶(5-FU)对人肿瘤细胞细胞毒性作用的增强作用。所用的人肿瘤细胞系有HeLa(子宫颈癌)、MCF-7(乳腺癌)、WI-38 CT-1(经Co-60γ射线照射在培养中转化的胚胎肺成纤维细胞)、KMM-1(骨髓瘤)和Raji(伯基特淋巴瘤)。所用的正常人细胞株是WI-38(正常人肺成纤维细胞)。通过HeLa、MCF-7、WI-38 CT-1和WI-38细胞的集落形成以及KMM-1和Raji细胞的细胞生长来确定细胞毒性作用。每种细胞系对干扰素或5-FU的敏感性不同。干扰素协同增强了5-FU对HeLa、WI-38 CT-1和KMM-1细胞的细胞毒性作用。对于Raji细胞,干扰素和5-FU联合使用的细胞毒性作用是相加的。在MCF-7和WI-38细胞中未观察到这两种药物联合使用的协同或相加致死作用。目前的结果表明,干扰素和5-FU有可能相互减少治疗癌症患者所需的另一种药物的用量。